Product Information

ESCITALOPRAM 5 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0419 per EA under NDC 82009003510. Its NADAC has been published 172 times since May 10, 2023.

FDA first approved this application on Sep 11, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ESCITALOPRAM 5 MG TABLET

escitalopram oxalate
$0.0419per EA

Strength

5 mg/1

NDC

82009003510

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ESCITALOPRAM OXALATE

Approval Type

Generic (ANDA)

FDA Application

ANDA090939

FDA Approved

9/11/2012

TE Code

AB

On Market Since

3/1/2023

Pharmacological Classes

Serotonin Reuptake Inhibitor
Serotonin Uptake Inhibitors

Price Statistics

The NADAC for ESCITALOPRAM 5 MG TABLET has been published 172 times since May 10, 2023, and over the history we have for it it has declined 6.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0419 per EA
All-time high$0.0501 (Apr 10, 2024)
All-time low$0.0328 (Nov 20, 2024)
52-week high$0.0472
52-week low$0.0412
Median price$0.0451
Average price$0.0440
Largest weekly change-27.3% (Nov 20, 2024)
Weeks tracked172
Tracking sinceMay 10, 2023

Price History

1W

-1.0%

1M

-1.0%

3M

+0.1%

6M

+0.4%

1Y

-11.1%

3Y

-13.0%

5Y

N/A

All

-6.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the escitalopram oxalate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of ESCITALOPRAM 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM 5 MG TABLET, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0419 per EA (NDC 82009003510), effective Aug 19, 2026.

How has the price of ESCITALOPRAM 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for ESCITALOPRAM 5 MG TABLET has declined 6.9%. It has been tracked across 172 weekly CMS publications since May 10, 2023.

What are the highest and lowest recorded NADAC prices for ESCITALOPRAM 5 MG TABLET?

Since May 10, 2023, the NADAC for ESCITALOPRAM 5 MG TABLET has ranged from a low of $0.0328 (Nov 20, 2024) to a high of $0.0501 (Apr 10, 2024), with a median of $0.0451 per EA.

Are there cheaper alternatives to ESCITALOPRAM 5 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of ESCITALOPRAM 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ESCITALOPRAM 5 MG TABLET?

ESCITALOPRAM 5 MG TABLET (NDC 82009003510) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.